Pauline Jen Ryan
Corporate Officer/Principal bij OCULAR THERAPEUTIX, INC.
Profiel
Pauline Jen Ryan is currently the Head of Business and Corporate Development at Ocular Therapeutix, Inc. and a Partner at Red Sky Partners LLC.
She was previously the Chief Executive Officer at Verik Bio, Inc. from 2012 to 2017, the Senior Vice President of Corporate Development and Operations at ImmunoGen, Inc. from 1999 to 2007, and the Senior Vice President of Business Operations at Proteostasis Therapeutics, Inc. from 2007 to 2011.
She received her undergraduate degree from Northwestern University and her MBA from Kellogg School of Management.
Actieve functies van Pauline Jen Ryan
| Bedrijven | Functie | Begin |
|---|---|---|
| OCULAR THERAPEUTIX, INC. | Corporate Officer/Principal | - |
| Red Sky Partners LLC | Corporate Officer/Principal | 01-07-2014 |
Eerdere bekende functies van Pauline Jen Ryan
| Bedrijven | Functie | Einde |
|---|---|---|
| Verik Bio, Inc. | Chief Executive Officer | 01-11-2017 |
| PROTEOSTASIS THERAPEUTICS, INC. | Corporate Officer/Principal | 01-08-2011 |
| IMMUNOGEN, INC. | Corporate Officer/Principal | 26-07-2007 |
Opleiding van Pauline Jen Ryan
| Northwestern University | Undergraduate Degree |
| Kellogg School of Management | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| IMMUNOGEN, INC. | Health Technology |
| OCULAR THERAPEUTIX, INC. | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
Proteostasis Therapeutics, Inc.
 Proteostasis Therapeutics, Inc. BiotechnologyHealth Technology Proteostasis Therapeutics, Inc. operates as a clinical stage biopharmaceutical company. It engages in the discovery and development of novel therapeutics to treat cystic fibrosis (CF) and other diseases caused by an imbalance in the proteostasis network. The company was founded by William Balch, Jeffery W. Kelly, Andrew Dillin, Richard I. Morimoto, Alfred Lewis Goldberg, Daniel Finley, Christopher T. Walsh, and Randall W. King in 2006 and is headquartered in Boston, MA. | Health Technology |
| Red Sky Partners LLC | |
| Verik Bio, Inc. |
